Publication
Article
CURE
Gastrointestinal Special IssueVolume1 Issue 1
Medical Illustration: Targeting HER2 in Gastric Cancer
Author(s):
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Articles in this issue
In Gastroesophageal Cancers, Better Prevention and Treatments Needed
Medical Illustration: Targeting HER2 in Gastric Cancer
Cholangiocarcinoma Research is Expanding, But Many Questions Are Still Unanswered
The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancers
Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies
Searching on all Fronts: Changing the Outlook for Those With Pancreatic Cancer
Right in the Gut: New Clues About Preventing and Treating Gastric Cancer
An Insight Into Gastric Cancers and Life Without a Stomach
Changing Lives With Immunotherapy
Related Content
